FDA NDC Directory · JSON-LD · Markdown
NDC 0121-0853 · HUMAN PRESCRIPTION DRUG · SUSPENSION
| Labeler / Manufacturer | PAI Holdings, LLC dba PAI Pharma |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA018615 |
| Dosage form / route | SUSPENSION · ORAL |
| Active ingredients | SULFAMETHOXAZOLE (200 mg/5mL) TRIMETHOPRIM (40 mg/5mL) |
| Marketing started | 20240805 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).